Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.
about
A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis.In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery.OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects.Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese childrenTroglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes.In Vitro and In Vivo Effects of Metformin on Osteopontin Expression in Mice Adipose-Derived Multipotent Stromal Cells and Adipose TissueReview article: Drug therapy for non-alcoholic fatty liver disease.Metformin overdose causes platelet mitochondrial dysfunction in humans.Nonalcoholic fatty liver disease: from clinical recognition to treatment.Serum leptin changes with metformin treatment in polycystic ovarian syndrome: correlation with ovulation, insulin and testosterone levels.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Cocktail supplement with rosiglitazone: a novel inducer for chicken preadipocyte differentiation in vitro.Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients.Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis.Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).Current and novel therapies for the treatment of nonalcoholic steatohepatitis.The Role of PPARγ in the Transcriptional Control by Agonists and Antagonists.Involvement of geranylgeranylation of Rho and Rac GTPases in adipogenic and RANKL expression, which was inhibited by simvastatin.β-Adrenoceptor assays.Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients.Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus.Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study Group.Metformin interacts with AMPK through binding to γ subunit.Dual Effects of Metformin on Adipogenic Differentiation of 3T3-L1 Preadipocyte in AMPK-Dependent and Independent Manners.
P2860
Q30306955-41B948C4-65AC-4C74-B522-4C648588BF26Q34163311-F0754081-0D8E-4741-9AAB-8AB65A37AE0DQ34448635-123F4175-3B37-49D4-8D11-B138D397BBC7Q34997528-67D13B2D-1BAA-4BA6-B373-D982A953A86AQ35042253-77811DD6-6F57-4534-84DA-1836805E4124Q35603472-087A47AC-157D-46C2-A12F-C92D46EA2A7AQ36360551-C7B69445-EE16-4E82-86B2-035E3F7221A6Q36928172-0DA1C83F-7545-4450-9E11-A65E01D34FE0Q37345907-329FCB93-DD9E-4C7A-939B-9525FC2A762CQ37413811-1E1CBAD1-2945-495A-A75D-FEE08333EE9BQ37570577-7B0A7D83-B8D0-470A-8D49-2500EF0FD6B8Q37626859-3EC64C66-B7F1-43A3-8F57-E1DB6039A9B5Q37716083-88840AD1-2BF3-463A-980B-0C838B48FDE3Q38110890-ACF00E52-398A-4AF4-A992-C09B566F126DQ38351961-298CEC44-F6C2-4115-B397-1180C603D0B2Q41832154-3FCB9E58-6A98-4A6E-8C9F-DF8E3BAE413CQ42185295-56CDB735-72EE-4C42-AA16-E7A2E46821C7Q45076373-94464586-E0D3-48B2-99B8-CD07757BAA5BQ46628767-7B72BB63-0D97-4CF5-8A47-CABBE0B8C4F8Q46675079-18A5454C-07EE-4B59-98CF-31A37A8C01CAQ47830415-57DDC901-1612-42D1-955A-77A6F5B09C5DQ51556296-2D1DC315-2FAA-4DA1-B592-A82DA2FAC24EQ51563791-66C5BEFA-CA58-47EE-97B3-43135B87FF21Q54508172-81CFC9D2-EC6C-44B1-AA85-AED11B690336Q54978492-213A0BC5-1F60-4CFB-9BBF-182340EB0C63
P2860
Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Effects of troglitazone and me ...... o distinct molecular pathways.
@en
type
label
Effects of troglitazone and me ...... o distinct molecular pathways.
@en
prefLabel
Effects of troglitazone and me ...... o distinct molecular pathways.
@en
P2093
P1476
Effects of troglitazone and me ...... o distinct molecular pathways.
@en
P2093
P304
P356
10.1016/S0006-2952(97)00229-3
P407
P577
1997-10-01T00:00:00Z